Literature DB >> 15492992

Intrasinusoidal cytotoxic CD8+ T cells in nodular regenerative hyperplasia of the liver.

Marianne Ziol1, Helene Poirel, Gisele N Kountchou, Olivier Boyer, Djamila Mohand, Luc Mouthon, Maryline Tepper, Jean-Gerard Guillet, Catherine Guettier, Martine Raphael, Michel Beaugrand.   

Abstract

Diffuse nodular regenerative hyperplasia (NRH) of the liver is an acquired architectural disturbance that can lead to portal hypertension. Although frequently associated with autoimmune or hematologic malignancies, its exact pathogenesis remains largely unknown. We observed CD8+ cytotoxic T cells in the liver sinusoids of 14 of 44 NRH patients and explored possible relationships between these lymphocytes and vascular damage. The immunophenotype of intrahepatic lymphocytes was determined using immunohistochemical analysis and endothelial injury using the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling method for apoptosis combined with endothelial cell labeling. Controls for the quantitative analysis of liver-infiltrating lymphocytes consisted of patients with chronic hepatitis C or normal liver (n = 13 and n = 6, respectively). Liver specimens from the 14 patients dislayed intrasinusoidal infiltrate composed of CD3+ and CD8+ lymphocytes, located near atrophic liver cell plates. Significantly more granzyme B+ and CD57+ lymphocytes were observed in NRH than chronic hepatitis C samples with quantitatively similar CD8+ infiltrates. Double-labeling revealed apoptotic endothelial sinusoidal cells in CD8+ T-cell-infiltrated areas in all NRH samples but never in chronic hepatitis C or normal livers. T-cell receptor rearrangement or immunoscope analysis suggested liver-specific polyclonal or oligoclonal T-cell expansions. Clinical and biological characteristics of the 14 patients were similar to those observed in the 30 patients with NRH devoid of lymphocytic infiltration. We report here that CD8+ cytotoxic T cells infiltrated the liver sinusoids of a high percentage (32%) of NRH patients and suggest that some NRH cases might result from chronic, cytotoxic CD8+ T-lymphocyte targeting of sinusoidal endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15492992     DOI: 10.1016/j.humpath.2004.06.016

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  11 in total

Review 1.  Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.

Authors:  Marek Hartleb; Krzysztof Gutkowski; Piotr Milkiewicz
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

2.  Nodular regenerative hyperplasia in common variable immunodeficiency.

Authors:  Ivan J Fuss; Julia Friend; Zhiqiong Yang; Jian Ping He; Lubna Hooda; James Boyer; Liqiang Xi; Mark Raffeld; David E Kleiner; Theo Heller; Warren Strober
Journal:  J Clin Immunol       Date:  2013-02-19       Impact factor: 8.317

3.  Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia.

Authors:  C Ward; M Lucas; J Piris; J Collier; H Chapel
Journal:  Clin Exp Immunol       Date:  2008-07-18       Impact factor: 4.330

4.  Indolent cytotoxic T cell lymphoproliferation associated with nodular regenerative hyperplasia: a common liver lesion in the context of common variable immunodeficiency disorder.

Authors:  Vanessa Szablewski; Céline René; Valérie Costes
Journal:  Virchows Arch       Date:  2015-10-22       Impact factor: 4.064

5.  Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5.

Authors:  Dita Gratzinger; Elaine S Jaffe; Amy Chadburn; John K C Chan; Daphne de Jong; John R Goodlad; Jonathan Said; Yasodha Natkunam
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

Review 6.  Idiopathic non-cirrhotic portal hypertension: a review.

Authors:  Jeoffrey N L Schouten; Joanne Verheij; Susana Seijo
Journal:  Orphanet J Rare Dis       Date:  2015-05-30       Impact factor: 4.123

7.  Portal hypertension from nodular regenerative hyperplasia of the liver treated with distal splenorenal shunt.

Authors:  Ja Greene; Pj DiPasco; Vp Koshenkov; As Livingstone
Journal:  J Surg Case Rep       Date:  2012-07-01

Review 8.  Portal hypertension as immune mediate disease.

Authors:  Sara Manti; Lucia Marseglia; Gabriella D'Angelo; Martina Filippelli; Caterina Cuppari; Eloisa Gitto; Claudio Romano; Teresa Arrigo; Carmelo Salpietro
Journal:  Hepat Mon       Date:  2014-06-07       Impact factor: 0.660

9.  Non-cirrhotic portal hypertension in an ankylosing spondylitis patient.

Authors:  Sukki Park; Ji Hyun Lee; Joon Sul Choi; Hyun Woo Kim; Beom Jin Shim; Won Kyu Choi; Sang Hyun Kim
Journal:  Yeungnam Univ J Med       Date:  2018-06-30

Review 10.  Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.

Authors:  Wendy Anne Boivin; Dawn Michelle Cooper; Paul Ryan Hiebert; David James Granville
Journal:  Lab Invest       Date:  2009-09-21       Impact factor: 5.502

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.